The current Average Equity is estimated to decrease to about 3.8 MHoth Therapeutics has a current ratio of 18.69, suggesting that it is liquid enough and is able to pay its financial obligations when due. On a scale of 0 to 100, Hoth Therapeutics holds a performance score of 6. The company retains a Market Volatility (i.e. Beta) of -0.1097, which attests to not very significant fluctuations relative to the market. Let's try to break down what Hoth Therapeutics's beta means in this case. As returns on the market increase, returns on owning Hoth Therapeutics are expected to decrease at a much lower rate. During the bear market, Hoth Therapeutics is likely to outperform the market. Although it is vital to follow Hoth Therapeutics current price history, it is good to be conservative about what you can do with the information regarding equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-one technical indicators for Hoth Therapeutics, which you can use to evaluate the performance of the firm. Please utilizes Hoth Therapeutics information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to make a quick decision on whether Hoth Therapeutics current trending patterns will revert.